HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Olaf Van Tellingen Selected Research
Olaf Van Tellingen Research Topics
Disease
4
Neoplasms (Cancer)
11/2013 - 01/2009
2
Neoplasm Metastasis (Metastasis)
11/2013 - 01/2009
1
Pancreatic Neoplasms (Pancreatic Cancer)
11/2013
1
Aneuploidy (Aneuploid)
09/2013
1
Glioblastoma (Glioblastoma Multiforme)
09/2013
1
Neutropenia
05/2009
1
Colonic Neoplasms (Colon Cancer)
01/2009
1
Melanoma (Melanoma, Malignant)
01/2009
1
Experimental Melanoma
01/2009
Drug/Important Bio-Agent (IBA)
1
Cytidine Deaminase
IBA
11/2013
1
Luciferases
IBA
11/2013
1
Crizotinib
IBA
11/2013
1
Gemcitabine
FDA Link
11/2013
1
Antimitotic Agents
IBA
09/2013
1
1- (4- (6- (2- (isopropylsulfonyl)phenylamino)- 9H- purin- 2- ylamino)- 3- ethoxyphenyl)piperidin- 4- ol
IBA
09/2013
1
Vincristine (Oncovin)
FDA Link
Generic
09/2013
1
Paclitaxel (Taxol)
FDA Link
Generic
09/2013
1
palomid 529
IBA
12/2011
1
Mechanistic Target of Rapamycin Complex 1
IBA
12/2011
1
Mechanistic Target of Rapamycin Complex 2
IBA
12/2011
1
Vinorelbine (Navelbine)
FDA Link
Generic
05/2009
1
tariquidar (XR9576)
IBA
05/2009
1
Rhodamines
IBA
05/2009
1
Thrombin
FDA Link
01/2009
1
Thromboplastin (Tissue Factor)
IBA
01/2009
1
Proteinase-Activated Receptors
IBA
01/2009
1
P-Selectin
IBA
01/2009
1
Fibrin
IBA
01/2009
1
Selectins
IBA
01/2009
1
Fibrinogen (Factor I)
FDA Link
01/2009
1
Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)
IBA
01/2009
1
Hirudins
IBA
01/2009
1
Anticoagulants
IBA
01/2009
1
Ligands
IBA
01/2009
Therapy/Procedure
1
Lasers (Laser)
11/2013